Biostatistical Analysis of Medicinal Plants for Treating Schizophrenia

Schizophrenia, a chronic and severe mental disorder, affects approximately 1% of the global population. Despite advances in pharmacotherapy, many patients experience suboptimal treatment responses or debilitating side effects. This has spurred interest in alternative treatments, including medicinal plants. This study aims to conduct a biostatistical analysis of medicinal plants used in treating schizophrenia, evaluating their efficacy and safety through rigorous statistical methods. And this study is dedicated to exploring the potential of traditional Chinese medicine in the treatment of schizophrenia. Specifically, a carefully formulated prescription consisting of 12g of Moutan Bark, 12g of Gardenia Fruit, 12g of Angelica Sinensis Root, 12g of Silk Tree Bark, 12g of Buddha's Hand Fruit, 12g of Fermented Soybean, 6g of Coptis Root, 6g of Cinnamon Bark, 15g of Chinese Yam Rhizome, 6g of Amomum Fruit, 6g of Licorice Root, 10g of Solomonseal Rhizome, 10g of Green Citrus Peel, and 15g of Spiny Ziziphus Seed was used for treatment. This meticulously blended formula demonstrated remarkable efficacy in rigorous clinical trials. After a period of treatment, patients not only experienced effective alleviation of symptoms but also saw a significant improvement in their quality of life. This achievement not only validates the unique value of traditional Chinese medicine in treating schizophrenia but also offers new treatment options and hope for a wide range of patients.